SlideShare uma empresa Scribd logo
1 de 33
Baixar para ler offline
Surveillance of Antimicrobial Resistance in India: from research capacity building to policy Child Health Research Project Coordination Meeting January 2002
Background   ,[object Object],[object Object],[object Object]
INCREASING PREVALENCE OF ANTIMICROBIAL RESISTANT MICROBES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
INCREASING PREVALENCE OF ANTIMICROBIAL RESISTANT MICROBES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Outline ,[object Object],[object Object],[object Object]
IndiaCLEN AMR Studies
IndiaCLEN IBIS Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IndiaCLEN IBIS Study Team  1993-2002 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IndiaCLEN IBIS & CAMR  Study Sites Chennai Delhi Vellor e Lucknow Nagpur Thiruvananthapuram  Mumbai CChennaihennai Chennai
INCLUSION CRITERIA IBIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Phase I & II  No.  recruited Phase I 1993 - 1998 5,798 Phase II 2000-Aug 01 Total 1,458 7,256* No. of  S. pneu- mo  isolates  307 183 490 * 58% < 2 y.o.; 92% children
IBIS Phase II Update Meningitis & Lobar Pneumonia Cases 41 8 8 6 7 5 7 # QC tests 183 29 101 9 8 11 25 #  S. pneumo 72 26 26  1 16 2 1  #  H. influenz. 308 3 152 38 9 0 106 # other fluids 1,117 355 168 102 199 196 97 # CSF samples 1,458 385 398 141 209 196 129 # re-cruited TOTAL Trivan-drum Vellore Nag-pur Mum-bai Luck-now Delhi
AMR  S.pneumoniae Time Trends
Newer AMR Studies ,[object Object],[object Object],[object Object],Studies to address these questions: - Phase II IBIS: afebrile children in OPD - CAMR: school children
IBIS Phase II Update  (2000 – Aug. 2001) Nasopharyngeal swabs from children without respiratory illnesses presenting at OPD 159 (20%) 32 45 0 5 48 29 #  S. pneumo 106 (13.4%) 38 16 0 6 31 15 #  H. influenz. 793 100 164 3 140 166 220 # of NP swabs  TOTAL Trivan-drum Vellore Nag-pur Mum-bai Luck-now Delhi
Community AMR Study Group  2000-2001 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CAMR Study Design ,[object Object],[object Object],[object Object],[object Object]
CAMR Update  (Aug. 28, 2000 – Sept. 31, 2001) Center Delhi Lucknow Nagpur Trivan- drum Vellore Total # tested 851  900  550  472  1,220  3,993 #  S. pneumo  211  157  117  83  352  920 #  H. infl.  94  54  51  64  47  310   # + both  181  26  26  107  285  625 Colonization  rates (%)  57.1  31.6  35.3  53.8  56.1  48.3
Comparison of AMR Patterns: Invasive  S. pneumo  vs. IBIS NP & CAMR data   (Thomas K & IBIS, 2002) IBIS p = 0.32 CAMR p = 0.08 IBIS p = 0.07 CAMR p = 0.001 IBIS p = 0.3 CAMR p = 0.005 IBIS p = 0.2 CAMR = 0.001 IBIS p = 0.9 CAMR p = 0.3 94 91  97 47 32  32 93  95  97 98  100 100 99  100 100
Comparison of AMR Patterns: Invasive  H. influenzae  vs. IBIS NP & CAMR data   (Thomas K & IBIS, 2002) IBIS p = 0.06 CAMR p = 0.001 IBIS p = 0.3 CAMR p = 0.2 IBIS p = 0.001 CAMR p = 0.001 IBIS p = 0.04 CAMR p = 0.001 IBIS p = 1.0 72 87 93 45  46 57 53 87  86 80 65 36 100 100
Serotype/serogroup distributions Invasive  S. pneumo  vs. CAMR isolates Serotype/group  IBIS Invasive  CAMR Isolates (n = 407)  (n = 1,064) 1 24.6%   - 6 10.8%   7.3% 19   6.3%  10.2% 7  5.2% - 5  4.2% - 14   3.7% - 4   2.9%   2.9% 18   2.9% - 3   1.5%   4.0%
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Policy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Other CHR Activities  Related to AMR
Expansion of AMR Surveillance ,[object Object],[object Object],[object Object]
Clinical Studies ,[object Object],[object Object],[object Object],[object Object]
Prescriber education and feedback ,[object Object],[object Object]
Economic Aspects of AMR ,[object Object],[object Object]
From Research Capacity Building to Policy
The case of IndiaCLEN IBIS ,[object Object],[object Object],[object Object]
The Case of IndiaCLEN IBIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The case of IndiaCLEN IBIS ,[object Object],[object Object],[object Object],[object Object]
The case of IndiaCLEN IBIS ,[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Meningitis Research Foundation
 
Dr Brenda Kwambana-Adams @ MRF's Meningitis and Septicaemia
Dr Brenda Kwambana-Adams @ MRF's Meningitis and SepticaemiaDr Brenda Kwambana-Adams @ MRF's Meningitis and Septicaemia
Dr Brenda Kwambana-Adams @ MRF's Meningitis and SepticaemiaMeningitis Research Foundation
 
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Meningitis Research Foundation
 
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...inventionjournals
 
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...Gaurav Gupta
 
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015Meningitis Research Foundation
 
Childhood immunisations: schedule changes and challenges
Childhood immunisations: schedule changes and challengesChildhood immunisations: schedule changes and challenges
Childhood immunisations: schedule changes and challengesMeningitis Research Foundation
 
Prevalence of nasal carriage of community associated methicillin-
Prevalence of nasal carriage of community associated methicillin-Prevalence of nasal carriage of community associated methicillin-
Prevalence of nasal carriage of community associated methicillin-Alexander Decker
 
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019Meningitis Research Foundation
 
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...asclepiuspdfs
 
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Meningitis Research Foundation
 
Emerging concepts in pneumococcal disease prevention in India sept 2011
Emerging concepts in pneumococcal disease prevention in India  sept 2011Emerging concepts in pneumococcal disease prevention in India  sept 2011
Emerging concepts in pneumococcal disease prevention in India sept 2011Gaurav Gupta
 
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospitalppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee HospitalMukherjeeHospital
 

Mais procurados (20)

Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
 
Imjh mar-2015-6
Imjh mar-2015-6Imjh mar-2015-6
Imjh mar-2015-6
 
Dr Brenda Kwambana-Adams @ MRF's Meningitis and Septicaemia
Dr Brenda Kwambana-Adams @ MRF's Meningitis and SepticaemiaDr Brenda Kwambana-Adams @ MRF's Meningitis and Septicaemia
Dr Brenda Kwambana-Adams @ MRF's Meningitis and Septicaemia
 
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
 
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...
Bacteriological and Mycological Profile of Chronic Suppurative Otitis Media I...
 
Novartis Group B Streptococcus vaccine programme
Novartis Group B Streptococcus vaccine programmeNovartis Group B Streptococcus vaccine programme
Novartis Group B Streptococcus vaccine programme
 
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...
Influenza Vaccine - Is it needed in Indian Children - presented at 1st IFICON...
 
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Childhood immunisations: schedule changes and challenges
Childhood immunisations: schedule changes and challengesChildhood immunisations: schedule changes and challenges
Childhood immunisations: schedule changes and challenges
 
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and SepticaemiaDr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
 
Prevalence of nasal carriage of community associated methicillin-
Prevalence of nasal carriage of community associated methicillin-Prevalence of nasal carriage of community associated methicillin-
Prevalence of nasal carriage of community associated methicillin-
 
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
 
Dr Anna Seale @ MRF's Meningitis and Septicaemia 2019
Dr Anna Seale @ MRF's Meningitis and Septicaemia 2019Dr Anna Seale @ MRF's Meningitis and Septicaemia 2019
Dr Anna Seale @ MRF's Meningitis and Septicaemia 2019
 
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...
Epidemio-clinical Profile of Atopic Dermatitis in Children in General Populat...
 
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
 
Emerging concepts in pneumococcal disease prevention in India sept 2011
Emerging concepts in pneumococcal disease prevention in India  sept 2011Emerging concepts in pneumococcal disease prevention in India  sept 2011
Emerging concepts in pneumococcal disease prevention in India sept 2011
 
Prevalence of mrsa
Prevalence of mrsaPrevalence of mrsa
Prevalence of mrsa
 
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and SepticaemiaDr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
 
Prof Joy Lawn @ MRF's Meningitis and Septicaemia 2019
Prof Joy Lawn @ MRF's Meningitis and Septicaemia 2019Prof Joy Lawn @ MRF's Meningitis and Septicaemia 2019
Prof Joy Lawn @ MRF's Meningitis and Septicaemia 2019
 
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospitalppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
ppt on Tdap vaccination by Dr. Alka Mukherjee - Mukherjee Hospital
 

Semelhante a Antimicro

DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdf
DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdfDIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdf
DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdfsudeepbhattacharyya
 
presented at ESPID PNEUMONET
presented at ESPID  PNEUMONETpresented at ESPID  PNEUMONET
presented at ESPID PNEUMONETivana haluskova
 
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...iosrjce
 
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...Dr.Samsuddin Khan
 
Ventilator-Associated Pneumonia Case Study
Ventilator-Associated Pneumonia Case StudyVentilator-Associated Pneumonia Case Study
Ventilator-Associated Pneumonia Case StudyErin Moore
 
Antimicrobial resistance in pathogens causing urinary tract infections in a r...
Antimicrobial resistance in pathogens causing urinary tract infections in a r...Antimicrobial resistance in pathogens causing urinary tract infections in a r...
Antimicrobial resistance in pathogens causing urinary tract infections in a r...Dr Muktikesh Dash, MD, PGDFM
 
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...John Blue
 
Ventilator-Associated Pneumonia Essay
Ventilator-Associated Pneumonia EssayVentilator-Associated Pneumonia Essay
Ventilator-Associated Pneumonia EssayAmber Wheeler
 
Influenza Vaccination in india - Pediatrician's Perspective, May 2016
Influenza Vaccination in india - Pediatrician's Perspective, May 2016Influenza Vaccination in india - Pediatrician's Perspective, May 2016
Influenza Vaccination in india - Pediatrician's Perspective, May 2016Gaurav Gupta
 
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...iosrjce
 
Report of the First National Anti TB Drug Resistance Survey India
Report of the First National Anti TB Drug Resistance Survey IndiaReport of the First National Anti TB Drug Resistance Survey India
Report of the First National Anti TB Drug Resistance Survey IndiaAnup Soans
 
TB Preventive Therapy
TB Preventive TherapyTB Preventive Therapy
TB Preventive TherapyRivu Basu
 
Synflorix what’s new in preventing pneumococcal disease (feb 2012)
Synflorix   what’s new in preventing pneumococcal disease (feb 2012)Synflorix   what’s new in preventing pneumococcal disease (feb 2012)
Synflorix what’s new in preventing pneumococcal disease (feb 2012)Gaurav Gupta
 
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku Joseph
VAP/HAP management guidelines  by IDSA/ATS (2016) -: Dr.Tinku JosephVAP/HAP management guidelines  by IDSA/ATS (2016) -: Dr.Tinku Joseph
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku JosephDr.Tinku Joseph
 

Semelhante a Antimicro (20)

DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdf
DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdfDIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdf
DIAGNOSTICS - Diagnosis of TB - A Nanodiagnostic Approach.pdf
 
presented at ESPID PNEUMONET
presented at ESPID  PNEUMONETpresented at ESPID  PNEUMONET
presented at ESPID PNEUMONET
 
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
 
HiBand Hep B
HiBand Hep B HiBand Hep B
HiBand Hep B
 
2003
20032003
2003
 
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...
Ocular inflammatory disease and ocular tuberculosis in a cohort of patients c...
 
Guia 2011
Guia 2011Guia 2011
Guia 2011
 
Ventilator-Associated Pneumonia Case Study
Ventilator-Associated Pneumonia Case StudyVentilator-Associated Pneumonia Case Study
Ventilator-Associated Pneumonia Case Study
 
Antimicrobial resistance in pathogens causing urinary tract infections in a r...
Antimicrobial resistance in pathogens causing urinary tract infections in a r...Antimicrobial resistance in pathogens causing urinary tract infections in a r...
Antimicrobial resistance in pathogens causing urinary tract infections in a r...
 
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...
 
Ventilator-Associated Pneumonia Essay
Ventilator-Associated Pneumonia EssayVentilator-Associated Pneumonia Essay
Ventilator-Associated Pneumonia Essay
 
Influenza Vaccination in india - Pediatrician's Perspective, May 2016
Influenza Vaccination in india - Pediatrician's Perspective, May 2016Influenza Vaccination in india - Pediatrician's Perspective, May 2016
Influenza Vaccination in india - Pediatrician's Perspective, May 2016
 
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...
Study of Bacterial Isolates and their Susceptibility Pattern in Chronic Suppu...
 
Report of the First National Anti TB Drug Resistance Survey India
Report of the First National Anti TB Drug Resistance Survey IndiaReport of the First National Anti TB Drug Resistance Survey India
Report of the First National Anti TB Drug Resistance Survey India
 
TB Preventive Therapy
TB Preventive TherapyTB Preventive Therapy
TB Preventive Therapy
 
Candida Score-5.pptx
Candida Score-5.pptxCandida Score-5.pptx
Candida Score-5.pptx
 
Synflorix what’s new in preventing pneumococcal disease (feb 2012)
Synflorix   what’s new in preventing pneumococcal disease (feb 2012)Synflorix   what’s new in preventing pneumococcal disease (feb 2012)
Synflorix what’s new in preventing pneumococcal disease (feb 2012)
 
doc
docdoc
doc
 
Sdrajani
SdrajaniSdrajani
Sdrajani
 
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku Joseph
VAP/HAP management guidelines  by IDSA/ATS (2016) -: Dr.Tinku JosephVAP/HAP management guidelines  by IDSA/ATS (2016) -: Dr.Tinku Joseph
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku Joseph
 

Último

PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxDr. Santhosh Kumar. N
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 

Último (20)

PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptx
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 

Antimicro

  • 1. Surveillance of Antimicrobial Resistance in India: from research capacity building to policy Child Health Research Project Coordination Meeting January 2002
  • 2.
  • 3.
  • 4.
  • 5.
  • 7.
  • 8.
  • 9. IndiaCLEN IBIS & CAMR Study Sites Chennai Delhi Vellor e Lucknow Nagpur Thiruvananthapuram  Mumbai CChennaihennai Chennai
  • 10.
  • 11. Phase I & II No. recruited Phase I 1993 - 1998 5,798 Phase II 2000-Aug 01 Total 1,458 7,256* No. of S. pneu- mo isolates 307 183 490 * 58% < 2 y.o.; 92% children
  • 12. IBIS Phase II Update Meningitis & Lobar Pneumonia Cases 41 8 8 6 7 5 7 # QC tests 183 29 101 9 8 11 25 # S. pneumo 72 26 26 1 16 2 1 # H. influenz. 308 3 152 38 9 0 106 # other fluids 1,117 355 168 102 199 196 97 # CSF samples 1,458 385 398 141 209 196 129 # re-cruited TOTAL Trivan-drum Vellore Nag-pur Mum-bai Luck-now Delhi
  • 13. AMR S.pneumoniae Time Trends
  • 14.
  • 15. IBIS Phase II Update (2000 – Aug. 2001) Nasopharyngeal swabs from children without respiratory illnesses presenting at OPD 159 (20%) 32 45 0 5 48 29 # S. pneumo 106 (13.4%) 38 16 0 6 31 15 # H. influenz. 793 100 164 3 140 166 220 # of NP swabs TOTAL Trivan-drum Vellore Nag-pur Mum-bai Luck-now Delhi
  • 16.
  • 17.
  • 18. CAMR Update (Aug. 28, 2000 – Sept. 31, 2001) Center Delhi Lucknow Nagpur Trivan- drum Vellore Total # tested 851 900 550 472 1,220 3,993 # S. pneumo 211 157 117 83 352 920 # H. infl. 94 54 51 64 47 310 # + both 181 26 26 107 285 625 Colonization rates (%) 57.1 31.6 35.3 53.8 56.1 48.3
  • 19. Comparison of AMR Patterns: Invasive S. pneumo vs. IBIS NP & CAMR data (Thomas K & IBIS, 2002) IBIS p = 0.32 CAMR p = 0.08 IBIS p = 0.07 CAMR p = 0.001 IBIS p = 0.3 CAMR p = 0.005 IBIS p = 0.2 CAMR = 0.001 IBIS p = 0.9 CAMR p = 0.3 94 91 97 47 32 32 93 95 97 98 100 100 99 100 100
  • 20. Comparison of AMR Patterns: Invasive H. influenzae vs. IBIS NP & CAMR data (Thomas K & IBIS, 2002) IBIS p = 0.06 CAMR p = 0.001 IBIS p = 0.3 CAMR p = 0.2 IBIS p = 0.001 CAMR p = 0.001 IBIS p = 0.04 CAMR p = 0.001 IBIS p = 1.0 72 87 93 45 46 57 53 87 86 80 65 36 100 100
  • 21. Serotype/serogroup distributions Invasive S. pneumo vs. CAMR isolates Serotype/group IBIS Invasive CAMR Isolates (n = 407) (n = 1,064) 1 24.6% - 6 10.8% 7.3% 19 6.3% 10.2% 7 5.2% - 5 4.2% - 14 3.7% - 4 2.9% 2.9% 18 2.9% - 3 1.5% 4.0%
  • 22.
  • 23.
  • 24. Other CHR Activities Related to AMR
  • 25.
  • 26.
  • 27.
  • 28.
  • 29. From Research Capacity Building to Policy
  • 30.
  • 31.
  • 32.
  • 33.

Notas do Editor

  1. Acute Respiratory infections has become the the most important cause of morbidity and mortality after the control of diarrheal diseases in the developing world. 3- 5 million people die anually due to ARI and most of them are children from the developing world. Most common etiological agents in community aquired ARI in children are S.pneumonia and H.infuenzae in ~60% and Respiroaty syncitial virus causing the bulk of the other infections. These are preventable infections at the present time.
  2. It is really been indeed a team effort by the investigators from different parts of India. Even though CMC has taken the leadership in microbiology and clinical coordination of the program. The success of the program has been the effort of all the members of the team.
  3. The inclusion criteria has changed over the last 7 years. In the first phase from 1993 to 1997 we laid a wide net to cast all the possible infections due to Pneumococci and H.influenzae. We noted that overall we had less than 3% prospective yeild from blood while there was about 15% yeild from CSF . While providing similar AMR and serotype data. So in the second phase of the study from 1998 we have concentrated more on meningitis as the source of our isolates. While keeping lobar pneumonia and frank septicemias also in the inclusion criteria. All subjects who had routine isolations in the laboratory from normaly sterile body fluids were also included in the study if they full filled in the clinical inclusion criteria.
  4. It is really been indeed a team effort by the investigators from different parts of India. Even though CMC has taken the leadership in microbiology and clinical coordination of the program. The success of the program has been the effort of all the members of the team.
  5. We can draw a number of important conclusions from the study: Pneumococcal resistance is currently low in the range of 3% in India. Emerging penicillin resistance is a cuase for concern and needs attention. ( referring to 6% intermediate resistance seen in 1999). Both the bacteria show very high levels of resistance to currently recommended drugs in the ARI program. Sero types included in the commercially available 9 or 11 valant vaccine give coverage for both adults and children.
  6. There is need to take steps to reduce emerging penicillin resistance in India. Development of antibiotic guidelines and hospital antibiotic policy some of the ways forward. We also need to control drug availability including that used in vetinary practice. There is need to systematically continue AMR surveillance so that we can evaluate the effect of interventional programs. And also provide information to guide rational antibiotic policy in the treatment of patient. There is no doubt that preventive strategies of reducing infections also reducing the antibiotic use and AMR development. The cost effectiveness of these vaccines in EPI program and high risk population will need to be evaluated.
  7. We are part of global AMR surveillance net work ANSOP We have initiated regional collaboration at South Asia level with ICDDRB
  8. It has been a very rewarding experience : Both in generating important data for the country But in developing the infrastructure for long term monitoring Lab strengthening, Reference centers in microbiology and data management.